Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.23.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss $ (5,954) $ (5,093)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 19 42
Amortization of right-of-use assets 63 60
Unrealized gain on investment   (3)
Share-based compensation expense 91 302
Changes in operating assets and liabilities:    
Prepaid and other assets 709 220
Trade and other payables 566 500
Accrued employee benefits (4) (11)
Lease liabilities (67) (62)
Net cash used in operating activities (4,577) (4,045)
Cash flows from investing activities:    
Net cash used in investing activities 0 0
Cash flows from financing activities:    
Proceeds from issuance of common stock, pre-funded warrants, and common warrants 30,883 17,884
Stock issuance costs (2,964) (1,869)
Net cash provided by financing activities 27,919 16,015
Effects of exchange rate changes on cash, cash equivalents, and restricted cash 45 501
Net increase in cash, cash equivalents, and restricted cash 23,387 12,471
Cash, cash equivalents, and restricted cash, beginning of period 2,490 4,076
Cash, cash equivalents, and restricted cash, end of period $ 25,877 $ 16,547